Tumor Angiogenesis and Modulators / / edited by Ke Xu.
Tumor angiogenesis is critical for tumor growth and progression. It is a multistep and complicated process, and the mechanism underlying tumor angiogenesis is not fully elucidated. Recent advances in tumor angiogenesis research have led to improved diagnosis, drug treatment, and clinical management...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | London, United Kingdom : : IntechOpen,, 2022. |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 online resource (164 pages) :; illustrations |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993581431704498 |
---|---|
ctrlnum |
(CKB)5700000000338582 (NjHacI)995700000000338582 (EXLCZ)995700000000338582 |
collection |
bib_alma |
record_format |
marc |
spelling |
Tumor Angiogenesis and Modulators / edited by Ke Xu. London, United Kingdom : IntechOpen, 2022. 1 online resource (164 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Tumor angiogenesis is critical for tumor growth and progression. It is a multistep and complicated process, and the mechanism underlying tumor angiogenesis is not fully elucidated. Recent advances in tumor angiogenesis research have led to improved diagnosis, drug treatment, and clinical management of cancer. However, novel strategies for cancer treatment are urgently needed, especially biomarker discovery for diagnosis, prognosis, and targeted therapy. This book presents the most recent advances in tumor angiogenesis. 1. Tumour Angiogenesis in Breast Cancer -- 2. Tumor Angiogenesis in Pituitary Adenoma -- 3. Role of Exosomes in Tumor Induced Neo-Angiogenesis -- 4. Role of the IL-6/Jak/Stat Pathway in Tumor Angiogenesis: Influence of Estrogen Status -- 5. Modulators of Tumor Angiogenesis: Insights into the Role of Galectin-3 and IL-17 Signaling -- 6. Vascular Endothelial Growth Factor (VEGF) in Liver Disease -- 7. Adipocytokines: Are They the Theory of Cancer Progression? -- 8. Extracellular Matrix in Tumor Angiogenesis. Tumors Blood-vessels Growth. Cancer Treatment. 1-80355-834-2 Xu, Ke, editor. |
language |
English |
format |
eBook |
author2 |
Xu, Ke, |
author_facet |
Xu, Ke, |
author2_variant |
k x kx |
author2_role |
TeilnehmendeR |
title |
Tumor Angiogenesis and Modulators / |
spellingShingle |
Tumor Angiogenesis and Modulators / 1. Tumour Angiogenesis in Breast Cancer -- 2. Tumor Angiogenesis in Pituitary Adenoma -- 3. Role of Exosomes in Tumor Induced Neo-Angiogenesis -- 4. Role of the IL-6/Jak/Stat Pathway in Tumor Angiogenesis: Influence of Estrogen Status -- 5. Modulators of Tumor Angiogenesis: Insights into the Role of Galectin-3 and IL-17 Signaling -- 6. Vascular Endothelial Growth Factor (VEGF) in Liver Disease -- 7. Adipocytokines: Are They the Theory of Cancer Progression? -- 8. Extracellular Matrix in Tumor Angiogenesis. |
title_full |
Tumor Angiogenesis and Modulators / edited by Ke Xu. |
title_fullStr |
Tumor Angiogenesis and Modulators / edited by Ke Xu. |
title_full_unstemmed |
Tumor Angiogenesis and Modulators / edited by Ke Xu. |
title_auth |
Tumor Angiogenesis and Modulators / |
title_new |
Tumor Angiogenesis and Modulators / |
title_sort |
tumor angiogenesis and modulators / |
publisher |
IntechOpen, |
publishDate |
2022 |
physical |
1 online resource (164 pages) : illustrations |
contents |
1. Tumour Angiogenesis in Breast Cancer -- 2. Tumor Angiogenesis in Pituitary Adenoma -- 3. Role of Exosomes in Tumor Induced Neo-Angiogenesis -- 4. Role of the IL-6/Jak/Stat Pathway in Tumor Angiogenesis: Influence of Estrogen Status -- 5. Modulators of Tumor Angiogenesis: Insights into the Role of Galectin-3 and IL-17 Signaling -- 6. Vascular Endothelial Growth Factor (VEGF) in Liver Disease -- 7. Adipocytokines: Are They the Theory of Cancer Progression? -- 8. Extracellular Matrix in Tumor Angiogenesis. |
isbn |
1-80355-835-0 1-80355-834-2 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC270 |
callnumber-sort |
RC 3270.8 T866 42022 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.99406 |
dewey-sort |
3616.99406 |
dewey-raw |
616.99406 |
dewey-search |
616.99406 |
work_keys_str_mv |
AT xuke tumorangiogenesisandmodulators |
status_str |
n |
ids_txt_mv |
(CKB)5700000000338582 (NjHacI)995700000000338582 (EXLCZ)995700000000338582 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Tumor Angiogenesis and Modulators / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1764995726759165952 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01479nam a2200301 i 4500</leader><controlfield tag="001">993581431704498</controlfield><controlfield tag="005">20230327192835.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230327s2022 enka o 000 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1-80355-835-0</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5700000000338582</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995700000000338582</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995700000000338582</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC270.8</subfield><subfield code="b">.T866 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.99406</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Tumor Angiogenesis and Modulators /</subfield><subfield code="c">edited by Ke Xu.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London, United Kingdom :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (164 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Tumor angiogenesis is critical for tumor growth and progression. It is a multistep and complicated process, and the mechanism underlying tumor angiogenesis is not fully elucidated. Recent advances in tumor angiogenesis research have led to improved diagnosis, drug treatment, and clinical management of cancer. However, novel strategies for cancer treatment are urgently needed, especially biomarker discovery for diagnosis, prognosis, and targeted therapy. This book presents the most recent advances in tumor angiogenesis.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">1. Tumour Angiogenesis in Breast Cancer -- 2. Tumor Angiogenesis in Pituitary Adenoma -- 3. Role of Exosomes in Tumor Induced Neo-Angiogenesis -- 4. Role of the IL-6/Jak/Stat Pathway in Tumor Angiogenesis: Influence of Estrogen Status -- 5. Modulators of Tumor Angiogenesis: Insights into the Role of Galectin-3 and IL-17 Signaling -- 6. Vascular Endothelial Growth Factor (VEGF) in Liver Disease -- 7. Adipocytokines: Are They the Theory of Cancer Progression? -- 8. Extracellular Matrix in Tumor Angiogenesis.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Tumors</subfield><subfield code="x">Blood-vessels</subfield><subfield code="x">Growth.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cancer</subfield><subfield code="x">Treatment.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-80355-834-2</subfield></datafield><datafield tag="700" ind1="0" ind2=" "><subfield code="a">Xu, Ke,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-04-15 13:21:08 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-12-05 16:10:45 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5343037520004498&Force_direct=true</subfield><subfield code="Z">5343037520004498</subfield><subfield code="8">5343037520004498</subfield></datafield></record></collection> |